Stem cells for enhancing recovery after stroke: A review

International Journal of Stroke

Volumn 4, Issue 2, 2009, Pages 101-110

  England, Tim ^a   Martin, Paul ^a   Bath, Philip M W ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Granulocyte colony stimulating factor; Ischaemic stroke; Stem cells

Indexed keywords

AMPHETAMINE; ANTINEOPLASTIC AGENT; COLONY STIMULATING FACTOR 1; CYCLOSPORIN; ERYTHROPOIETIN; FIBRINOLYTIC AGENT; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; METHYLPREDNISOLONE; PLACEBO; PROTEIN ANTIBODY; RECOMBINANT COLONY STIMULATING FACTOR 1; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT STEM CELL FACTOR; STEM CELL FACTOR;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANGIOGENESIS; APOPTOSIS; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BRAIN INFARCTION; CELL ACTIVITY; CELL DIFFERENTIATION; CELL IMMORTALIZATION; CELL LINEAGE; CELL POPULATION; CELL RENEWAL; CELL STIMULATION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COGNITIVE DEFECT; CORD BLOOD STEM CELL TRANSPLANTATION; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG MECHANISM; EMBRYONIC STEM CELL; ENCEPHALITIS; FETUS CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUNTINGTON CHOREA; INFECTION; MESENCHYMAL STEM CELL TRANSPLANTATION; MITOSIS; MOTOR DYSFUNCTION; MULTIPOTENT STEM CELL; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL TRANSPLANTATION; NEUROPROTECTION; NEUTROPENIA; NONHUMAN; PARKINSON DISEASE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PHYSIOTHERAPY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SENSORY DYSFUNCTION; STEM CELL MOBILIZATION; STEM CELL TRANSPLANTATION;

ANIMALS; CLINICAL TRIALS AS TOPIC; HUMANS; STEM CELL TRANSPLANTATION; STEM CELLS; STROKE;

EID: 65449135553     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2009.00253.x     Document Type: Review

References (119)

1. Rothwell PM, Coull AJ, Silver LE et al. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet 2005; 366:1773-83.
2. Bath PM, Lees KR. ABC of arterial and venous disease. Acute stroke. BMJ 2000; 320:920-3.
3. Bath PM, Lindenstrom E, Boysen G et al. Tinzaparin in acute ischaemic stroke (TAIST): A randomised aspirin-controlled trial. Lancet 2001; 358:702-10.
4. Ferro JM, Davalos A. Other neuroprotective therapies on trial in acute stroke. Cerebrovasc Dis 2006; 2:127-30.
5. The ATLANTIS ECASS and NINDS rt-PA Study Group Investigators. Association of outcome with early stroke treatment: Pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004; 363:768-813.
6. Vahedi K, Hofmeijer J, Juettler E et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: A pooled analysis of three randomised controlled trials [see comment]. Lancet Neurol 2007; 6:215-22.
7. Stroke Unit Trialists' Collaboration. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev 2007: CD000197.
8. Cowan CA, Melton DA. "Stemness": Definitions, criteria and standards; in Lanza R (ed): Handbook of Stem Cells, 1st edn. Burlington, San Diego, USA: Elsevier Xcademic Press, 2004: xxv-xxxi.
9. Safety and efficacy study of autologous stem cell transplantation for early onset type I diabetes mellitus. Available at http://clinicaltrials.gov/ct/show/NCT00315133 (accessed 28 January 2008).
10. Donor stem cell transplant in treating patients with hematologic cancer. Available at http://clinicaltrials.gov/ct/show/NCT00054327 (accessed 28 January 2008).
11. Freed CR, Greene PE, Breeze RE et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. New Engl J Med 2001; 344:710-9.
12. Stamm C, Kleine HD, Choi YH et al. Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: Safety and efficacy studies. J Thorac Cardiovasc Surg 2007; 133:717-25.
13. Eriksson PS, Perfilieva E, Bjork-Eriksson T et al. Neurogenesis in the adult human hippocampus. Nat Med 1998; 4:1313-7.
14. Roy NS, Wang S, Jiang L et al. In vitro neurogenesis by progenitor cells isolated from the adult human hippocampus. Nat Med 2000; 6:271-7.
15. Richardson RM, Holloway KL, Bullock MR, Broaddus WC, Fillmore HL. Isolation of neuronal progenitor cells from the adult human neocortex. Acta Neurochir 2006; 148:773-7.
16. Zhao M, Momma S, Delfani K et al. Evidence for neurogenesis in the adult mammalian substantia nigra. Proc Natl Acad Sci USA 2003; 100:7925-30.
17. Pagano SF, Impagnatiello F, Girelli M et al. Isolation and characterization of neural stem cells from the adult human olfactory bulb. Stem Cells 2000; 18:295-300.
18. Arvidsson A, Collin T, Kirik D, Kokaia Z, Lindvall O. Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med 2002; 8:963-70.
19. Kukekov VG, Laywell ED, Suslov O et al. Multipotent stem/progenitor cells with similar properties arise from two neurogenic regions of adult human brain. Exp Neurol 1999; 156:333-44.
20. Chu K, Kim M, Park KI et al. Human neural stem cells improve sensorimotor deficits in the adult rat brain with experimental focal ischemia. Brain Res 2004; 1016:145-53.
21. Darsalia V, Kallur T, Kokaia Z. Survival, migration and neuronal differentiation of human fetal striatal and cortical neural stem cells grafted in stroke-damaged rat striatum. Eur J Neurosci 2007; 26:605-14.
22. Seaberg RM, Smukler SR, van der Kooy D. Intrinsic differences distinguish transiently neurogenic progenitors from neural stem cells in the early postnatal brain. Dev Biol 2005; 278:71-85.
23. Buhnemann C, Scholz A, Bernreuther C et al. Neuronal differentiation of transplanted embryonic stem cell-derived precursors in stroke lesions of adult rats. Brain 2006; 129:3238-48.
24. Wei L, Cui L, Snider BJ et al. Transplantation of embryonic stem cells overexpressing Bcl-2 promotes functional recovery after transient cerebral ischemia. Neurobiol Dis 2005; 19:183-93.
25. Pollard S, Conti L, Smith A. Exploitation of adherent neural stem cells in basic and applied neurobiology. Regen Med 2006; 1:111-8.
26. Erdo F, Buhrle C, Blunk J et al. Host-dependent tumorigenesis of embryonic stem cell transplantation in experimental stroke. J Cereb Blood Flow Metab 2003; 23:780-5.
27. Schumacher JM, Ellias SA, Palmer EP et al. Transplantation of embryonic porcine mesencephalic tissue in patients with PD. Neurology 2000; 54:1042-50.
28. Dunnett SB, Rosser AE. Stem cell transplantation for Huntington's disease. Exp Neurol 2007; 203:279-92.
29. Dinsmore JH, Manhart C, Raineri R, Jacoby DB, Moore A. No evidence for infection of human cells with porcine endogenous retrovirus (PERV) after exposure to porcine fetal neuronal cells. Transplantation 2000; 70:1382-9.
30. Andrews PW, Damjanov I, Simon D et al. Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro. Lab Invest 1984; 50:147-62.
31. Trojanowski JQ, Kleppner SR, Hartley RS et al. Transfectable and transplantable postmitotic human neurons: A potential "platform" for gene therapy of nervous system diseases. Exp Neurol 1997; 144:92-7.
32. Bianco P, Robey G. Skeletal stem cells; in Lanza R (ed): Handbook of Stem Cells, 1st edn. Burlington, San Diego, USA: Elsevier Academic Press, 2004: 415-4125.
33. Sanchez-Ramos J, Song S, Cardozo-Pelaez F et al. Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol 2000; 164:247-56.
34. Mezey E, Chandross KJ, Harta G, Maki RA, McKercher SR. Turning blood into brain: Cells bearing neuronal antigens generated in vivo from bone marrow. Science 2000; 290:1779-82.
35. Li Y, Chen J, Chopp M. Adult bone marrow transplantation after stroke in adult rats. Cell Transplant 2001; 10:31-40.
36. Zhao LR, Duan WM, Reyes M, Keene CD, Verfaillie CM, Low WC. Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats. Exp Neurol 2002; 174:11-20.
37. Terada N, Hamazaki T, Oka M et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 2002; 416:542-5.
38. Rossi DJ, Bryder D, Seita J, Nussenzweig A, Hoeijmakers J, Weissman IL. Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature 2007; 447:725-9.
39. Chen J, Sanberg PR, Li Y et al. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 2001; 32:2682-8.
40. Nagai A, Kim WK, Lee HJ et al. Multilineage potential of stable human mesenchymal stem cell line derived from fetal marrow. PLoS ONE [Electronic Resource] 2007; 2:e1272.
41. Sokolova I, Fedotova O, Zin'Kova N, Kruglyakov P, Polyntsev D. Effect of mesenchymal stem cell transplantation on cognitive function in rats with ischaemic stroke. Bull Exp Biol Med 2006; 2:511-4.
42. Borlongan CV, Evans A, Yu G, Hess DC. Limitations of intravenous human bone marrow CD133+ cell grafts in stroke rats. Brain Res 2005; 1048:116-22.
43. Guo Y, Lubbert M, Engelhardt M. CD34-hematopoietic stem cells: Current concepts and controversies. Stem Cells 2003; 21:15-20.
44. Shintani S, Murohara T, Ikeda H et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001; 103:2776-9.
45. Dunac A, Frelin C, Popolo-Blondeau M, Chatel M, Mahagne M, Philip P. Neurological and functional recovery in human stroke are associated with peripheral blood CD34+ cell mobilization. J Neurol 2007; 254:327-32.
46. Hennemann B, Ickenstein G, Sauerbruch S et al. Mobilization of CD34+ hematopoietic cells, colony-forming cells and long-term culture-initiating cells into the peripheral blood of patients with an acute cerebral ischemic insult. Cytotherapy 2008; 10:303-11.
47. Taguchi A, Matsuyama T, Moriwaki H et al. Circulating CD34-positive cells provide an index of cerebrovascular function. Circulation 2004; 109:2972-5.
48. Schmidt-Lucke C, Rossig L, Fichtlscherer S et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: Proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005; 111:2981-7.
49. Jung KH, Chu K, Lee ST et al. Identification of neuronal outgrowth cells from peripheral blood of stroke patients. Ann Neurol 2008; 63:312-22.
50. Jin K, Mao XO, Sun Y, Xie L, Greenberg DA. Stem cell factor stimulates neurogenesis in vitro and in vivo. J Clin Invest 2002; 110:311-9.
51. Brines ML, Ghezzi P, Keenan S et al. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci USA 2000; 97:10526-31.
52. Gibson CL, Bath PM, Murphy SP. G-CSF reduces infarct volume and improves functional outcome after transient focal cerebral ischemia in mice. J Cereb Blood Flow Metab 2005; 25:431-9.
53. Schabitz WR, Kruger C, Pitzer C et al. A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF). J Cereb Blood Flow Metab 2008; 28:29-43.
54. Vincent VA, Robinson CC, Simsek D, Murphy GM. Macrophage colony stimulating factor prevents NMDA-induced neuronal death in hippocampal organotypic cultures. J Neurochem 2002; 82:1388-97.
55. Schabitz WR, Kollmar R, Schwaninger M et al. Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia. Stroke 2003; 34:745-51.
56. Kollmar R, Henninger N, Urbanek C, Schabitz W, Schneider A, Schwab S. Effects of G-CSF in combination with rt-PA after experimental thromboembolic stroke. Akt Neurol 2004; 31:S1,V88.
57. Kollmar R, Henninger N, Urbanek C, Schwab S. G-CSF and rt-PA for the treatment of experimental embolic stroke. Cerebrovasc Dis 2007; 23(Suppl. 2):23.
58. Shyu WC, Lin SZ, Yang HI et al. Functional recovery of stroke rats induced by granulocyte colony-stimulating factor-stimulated stem cells. Circulation 2004; 110:1847-54.
59. Lee ST, Chu K, Jung KH et al. Granulocyte colony-stimulating factor enhances angiogenesis after focal cerebral ischemia. Brain Res 2005; 1058:120-8.
60. Sehara Y, Hayashi T, Deguchi K et al. Potentiation of neurogenesis and angiogenesis by G-CSF after focal cerebral ischemia in rats. Brain Res 2007; 1151:142-9.
61. Schneider A, Kruger C, Steigleder T et al. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest 2005; 115:2083-98.
62. Taguchi A, Wen Z, Myojin K et al. Granulocyte colony-stimulating factor has a negative effect on stroke outcome in a murine modelwa. Eur J Neurosci 2007; 26:126-33.
63. Zhao LR, Berra HH, Duan WM et al. Beneficial effects of hematopoietic growth factor therapy in chronic ischemic stroke in rats. Stroke 2007; 38:2804-11.
64. Matchett GA, Calinisan JB, Matchett GC, Martin RD, Zhang JH. The effect of granulocyte-colony stimulating factor in global cerebral ischemia in rats. Brain Res 2007; 1136:200-7.
65. Komine-Kobayashi M, Zhang N, Liu M et al. Neuroprotective effect of recombinant human granulocyte colony-stimulating factor in transient focal ischemia of mice. J Cereb Blood Flow Metab 2006; 26:402-13.
66. Gibson CL, Jones NC, Prior MJ, Bath PM, Murphy SP. G-CSF suppresses edema formation and reduces interleukin-1beta expression after cerebral ischemia in mice. J Neuropathol Exp Neurol 2005; 64:763-9.
67. Jacobs KM, Donoghue JP. Reshaping the cortical motor map by unmasking latent intracortical connections. Science 1991; 251:944-7.
68. Carmichael ST, Chesselet MF. Synchronous neuronal activity is a signal for axonal sprouting after cortical lesions in the adult. J Neurosci 2002; 22:6062-70.
69. Bliss TV, Collingridge GL. A synaptic model of memory: Long-term potentiation in the hippocampus. Nature 1993; 361:31-9.
70. Pantano P, Baron JC, Samson Y, Bousser MG, Derouesne C, Comar D. Crossed cerebellar diaschisis. Further studies. Brain 1986; 109:677-94.
71. Jin K, Minami M, Lan JQ et al. Neurogenesis in dentate subgranular zone and rostral subventricular zone after focal cerebral ischemia in the rat. Proc Natl Acad Sci USA 2001; 98:4710-5.
72. Vaynman S, Gomez-Pinilla F. License to run: Exercise impacts functional plasticity in the intact and injured central nervous system by using neurotrophins. Neurorehabil Neural Repair 2005; 19:283-95.
73. Sprigg N, Bath P. Pharmacological enhancement of recovery from stroke. Curr Med Literature Stroke Rev 2005; 8:33-9.
74. Taguchi A, Soma T, Tanaka H et al. Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest 2004; 114:330-8.
75. Ishibashi S, Sakaguchi M, Kuroiwa T et al. Human neural stem/progenitor cells, expanded in long-term neurosphere culture, promote functional recovery after focal ischemia in Mongolian gerbils. J Neurosci Res 2004; 78:215-23.
76. Kelly S, Bliss TM, Shah AK et al. Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. Proc Natl Acad Sci USA 2004; 101:11839-44.
77. Nystedt J, Makinen S, Laine J, Jolkkonen J. Human cord blood CD34+ cells and behavioral recovery following focal cerebral ischemia in rats. Acta Neurobiol Exp 2006; 66:293-300.
78. Makinen S, Kekarainen T, Nystedt J et al. Human umbilical cord blood cells do not improve sensorimotor or cognitive outcome following transient middle cerebral artery occlusion in rats. Brain Res 2006; 1123:207-15.
79. Vendrame M, Gemma C, de Mesquita D et al. Anti-inflammatory effects of human cord blood cells in a rat model of stroke. Stem Cells Dev 2005; 14:595-604.
80. Lee SH, Kim YJ, Lee KM, Ryu S, Yoon BW. Ischemic preconditioning enhances neurogenesis in the subventricular zone. Neuroscience 2007; 146:1020-31.
81. Ray J, Gage FH. Differential properties of adult rat and mouse brain-derived neural stem/progenitor cells. Mol Cell Neurosci 2006; 31:560-73.
82. Yagita Y, Kitagawa K, Ohtsuki T et al. Neurogenesis by progenitor cells in the ischemic adult rat hippocampus. Stroke 2001; 32: 1890-6.
83. Minger S, Ekonomou A, Carta E, Chinoy A, Perry R, Ballard C. Endogenous neurogenesis in the human brain following cerebral infarction. Regen Med 2007; 2:69-74.
84. Bogousslavsky J, Victor S, Salinas E et al. Fiblast (Trafermin) in acute stroke: Results of the European-Australian phase II/III safety and efficacy trial. Cerebrovasc Dis 2002; 14:239-51.
85. Lees KR, Muir KW. Excitatory amino acid antagonists for acute stroke. Cochrane Database Syst Rev 2003; CD001244.
86. Zhang R, Zhang Z, Wang L et al. Activated neural stem cells contribute to stroke-induced neurogenesis and neuroblast migration toward the infarct boundary in adult rats. J Cereb Blood Flow Metab 2004; 24:441-8.
87. Sinden JD. ReNeuron group plc. Regen Med 2006; 1:143-7.
88. Pollock K, Stroemer P, Patel S et al. A conditionally immortal clonal stem cell line from human cortical neuroepithelium for the treatment of ischemic stroke. Exp Neurol 2006; 199:143-55.
89. Castro RF, Jackson KA, Goodell MA, Robertson CS, Liu H, Shine HD. Failure of bone marrow cells to transdifferentiate into neural cells in vivo. Science 2002; 297:1299.
90. Wagers AJ, Sherwood RI, Christensen JL, Weissman IL. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science 2002; 297:2256-9.
91. Vendrame M, Cassady J, Newcomb J et al. Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume. Stroke 2004; 35:2390-5.
92. Majka M, Janowska-Wieczorek A, Ratajczak J et al. Numerous growth factors, cytokines, and chemokines are secreted by human CD34(+) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. Blood 2001; 97:3075-85.
93. Xiao J, Nan Z, Motooka Y, Low WC. Transplantation of a novel cell line population of umbilical cord blood stem cells ameliorates neurological deficits associated with ischemic brain injury. Stem Cells Dev 2005; 14:722-33.
94. Chen J, Li Y, Wang L et al. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 2001; 32:1005-11.
95. Hoehn M, Kustermann E, Blunk J et al. Monitoring of implanted stem cell migration in vivo: A highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc Natl Acad Sci USA 2002; 99:16267-72.
96. Jendelova P, Herynek V, Urdzikova L et al. Magnetic resonance tracking of human CD34 progenitor cells separated by means of immunomagnetic selection and transplanted into injured rat brain. Cell Transplant 2005; 14:173-82.
97. Wang Y, Deng Y, Zhou GQ. SDF-1alpha/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model. Brain Res 2008; 1195:104-12.
98. Kondziolka D, Wechsler L, Goldstein S et al. Transplantation of cultured human neuronal cells for patients with stroke. Neurology 2000; 55:565-9.
99. Nelson PT, Kondziolka D, Wechsler L et al. Clonal human (hNT) neuron grafts for stroke therapy: Neuropathology in a patient 27 months after implantation. Am J Pathol 2002; 160:1201-6.
100. Kleppner SR, Robinson KA, Trojanowski JQ, Lee VM. Transplanted human neurons derived from a teratocarcinoma cell line (NTera-2) mature, integrate, and survive for over 1 year in the nude mouse brain. J Comp Neurol 1995; 357:618-32.
101. Kondziolka D, Steinberg GK, Wechsler L et al. Neurotransplantation for patients with subcortical motor stroke: A phase 2 randomized trial. J Neurosurg 2005; 103:38-45.
102. Savitz SI, Dinsmore J, Wu J, Henderson GV, Stieg P, Caplan LR. Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: A preliminary safety and feasibility study. Cerebrovasc Dis 2005; 20:101-7.
103. Bang OY, Lee JS, Lee PH, Lee G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol 2005; 57:874-82.
104. De Keyser J. Autologous mesenchymal stem cell transplantation in stroke patients [comment]. Ann Neurol 2005; 58: 653-4; author reply 654-5.
105. Bang OY. An apology: Inadvertent error in our article published in June 2005 issue of the Ann Neurol (Ann Neurol 2005;57:874-882). Ann Neurol 2005; 58: 659.
106. Sprigg N, Bath PM, Zhao L et al. Granulocyte-colony-stimulating factor mobilizes bone marrow stem cells in patients with subacute ischemic stroke: The Stem cell Trial of recovery EnhanceMent after Stroke (STEMS) pilot randomized, controlled trial (ISRCTN 16784092). Stroke 2006; 37:2979-83.
107. Shyu WC, Lin SZ, Lee CC, Liu DD, Li H. Granulocyte colony-stimulating factor for acute ischemic stroke: A randomized controlled trial. CMAJ 2006; 174:927-33.
108. Zhang JJ, Deng M, Zhang Y, Sui W, Wang L, Sun A. A short-term assessment of Recombinant Granulocyte-Stimulating factor (RHG-CSF) in treatment of acute cerebral infarction. Cerebrovasc Dis 2006; 21(Suppl. 4):143.
109. Bath PM, Sprigg N. Colony stimulating factors (including erythropoietin, granulocyte colony stimulating factor and analogues) for stroke. Cochrane Database Syst Rev 2006; 3:CD005207.
110. Cavallaro AM, Lilleby K, Majolino I et al. Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor. Bone Marrow Transplant 2000; 25:85-9.
111. Sohngen D, Wienen S, Siebler M et al. Analysis of rhG-CSF-effects on platelets by in vitro bleeding test and transcranial Doppler ultrasound examination. Bone Marrow Transplant 1998; 22:1087-90.
112. Ioannidis JP. Contradicted and initially stronger effects in highly cited clinical research. JAMA 2005; 294:218-28.
113. Anonymous. Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke 1999; 30:2752-8.
114. Lee ST, Chu K, Jung KH et al. Anti-inflammatory mechanism of intravascular neural stem cell transplantation in haemorrhagic stroke. Brain 2008; 131:616-29.
115. Kim JM, Lee ST, Chu K et al. Systemic transplantation of human adipose stem cells attenuated cerebral inflammation and degeneration in a hemorrhagic stroke model. Brain Res 2007; 1183:43-50.
116. Jin K, Sun Y, Xie L et al. Comparison of ischemia-directed migration of neural precursor cells after intrastriatal, intraventricular, or intravenous transplantation in the rat. Neurobiol Dis 2005; 18:366-74.
117. Borlongan CV, Hadman M, Sanberg CD, Sanberg PR. Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke 2004; 35:2385-9.
118. Modo M, Mellodew K, Cash D et al. Mapping transplanted stem cell migration after a stroke: A serial, in vivo magnetic resonance imaging study. Neuroimage 2004; 21:311-7.
119. Martin PA, Coveney C, Kraft A, Brown N, Bath P. Commercial development of stem cell technology: Lessons from the past, strategies for the future. Regen Med 2006; 1:801-7.